Rapid Test Covid-19 Antibody - Onsite
The OnSite COVID-19 IgG/IgM Rapid Test is a single use lateral flow immunoassay rapid test intended for qualitative detection and differentiation of anti-SARS-CoV-2 IgG and IgM antibodies in human serum and plasma or whole blood containing EDTA, heparin or citrate anti-coagulants. The OnSite COVID-19 IgG/IgM Rapid Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. For prescription use only. For in vitro diagnostic use only.
Features:
- The OnSite COVID-19 IgG/IgM Rapid Test is designed to detect anti-SARS-CoV-2 IgG and IgM antibodies in either human serum, plasma or whole blood within 15 minutes.
- This test is easy-to-use, with basic equipment needs.
- The OnSite COVID-19 IgG/IgM Rapid Test has 97.1% sensitivity and 97.8% specificity, making it one of the most effective tests for detecting previous exposure to anti-SARS CoV-2 virus.
- Finger prick specimen allows testing at point-of-care, saving crucial time.
- Complementary to PCR by detecting immune response
- Compatible with CTK Rapid Test Reader (RTR-1)
200 tests per hour in batch mode
Capable of connecting to Laboratory Information System (LIS)
Built-in barcode reader provides faster test setup
Stores up to 1,000 results, presented on screen, via printout, or uploaded to database
Customer Rating & Review